Virginia Arrazubi

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 214 citations

Gortec 2014-01 Tpextreme, Neoadjuvant Therapy, Medicine +11

The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients

Juan Ignacio Arrarás, Javier Suárez, Fernando Arias de la Vega et al. · Clinical & Translational Oncology · 2011 · 66 citations

Quality Of Life, Life Questionnaire, Life Assessment +8

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial

Fernando Rivera, C. Romero, Paula Jiménez‐Fonseca et al. · Cancer Chemotherapy and Pharmacology · 2019 · 63 citations · Full text

Stent or surgery for incurable obstructive colorectal cancer: an individualized decisión

Javier Suárez, Javier Jiménez, Ruth Vera et al. · International Journal of Colorectal Disease · 2009 · 36 citations

Surgical Oncology, Oncology, Gastrointestinal Oncology +7

Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial

Virginia Arrazubi, Elena Mata, María Luisa Antelo et al. · Annals of Surgical Oncology · 2019 · 32 citations

Patients Undergoing Resection, Surgical Oncology, Hepatology +11